Annals of Oncology
(ISSN: 0923-7534, 1569-8041)
Articles Available on Medscape
- A Phase III Randomized Study of Gemcitabine and Cisplatin With or Without PF-3512676 (TLR9 Agonist) as First-Line Treatment of Advanced Non-Small-Cell Lung Cancer
- New Treatment Modalities in Advanced Thyroid Cancer
- Efficacy of Capecitabine Versus 5-Fluorouracil in Colorectal and Gastric Cancers
- Impact of Lapatinib Plus Trastuzumab Versus Single-Agent Lapatinib on Quality of Life of Patients With Trastuzumab-Refractory HER2+ Metastatic Breast Cancer
- Efficacy and Treatment Tolerance in Older Patients With NSCLC
Annals of Oncology's Latest Table of Contents
2012 - 23 (2)
- "The only thing I know is that I know nothing": 5-fluorouracil in human milk.
- Heine H. Hansen, 1938-2011: a European oncologist.
- Screening mammography and socioeconomic inequalities in breast cancer survival.
- Second malignancies among Waldenstrom macroglobulinemia patients: small samples and sparse data.
- Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study.
- A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group.
- Lung cancer physicians' referral practices for palliative care consultation.
- A meta-analysis of coffee consumption and pancreatic cancer.
- CMF revisited in the 21st century.
- Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomes.
- Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapy.
- T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results.
- Small bowel adenocarcinoma copy number profiles are more closely related to colorectal than to gastric cancers.
- Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study.
- Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors.
- External validation of nomogram for the prediction of recurrence after curative resection in early gastric cancer.
- Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infection.
- A meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma risk.
- Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989.
- Intracranial hemorrhage in patients with cancer treated with bevacizumab: the Memorial Sloan-Kettering experience.
- Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma.
- Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome.
- Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma--data from the Czech registry.
- Toxicity burden score: a novel approach to summarize multiple toxic effects.
- Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4).
- A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma.
- A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study.
- First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07).
- Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation.
- Risk of second cancers in Waldenstrom macroglobulinemia.
- Breast cancer subtypes and outcome after local and regional relapse.
- The hOGG1 mutant genotype is associated with prostate cancer susceptibility and aggressive clinicopathological characteristics in the Korean population.
- Does an organised screening programme reduce the inequalities in breast cancer survival?
- Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network.
